Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03273387

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension (TRIMETA-PH)

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension Patients in National Cardiovascular Center Harapan Kita Hospital Indonesia

Sponsor: Indonesia University

Conditions Precapillary Pulmonary Hypertension

Interventions Placebo oral capsule Trimetazidine

Updated 6 times since 2017 Last updated: Sep 11, 2019 Started: Sep 10, 2017 Primary completion: Nov 1, 2018 Completion: Dec 14, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Precapillary Pulmonary Hypertension and is currently completed. Indonesia University leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Nov 2019 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

Status: Unknown Status → Completed
Oct 2019 — Nov 2019 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Oct 2017 — Oct 2019 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indonesia University

Data source: Indonesia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia